Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Berridge

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
BMC Cardiovascular Disorders|September 27, 2025
Derivation of ultrasound and electrocardiogram cardiac reference ranges for Mus musculus using the collaborative cross and identification of new cardiac modelsJulia L Popp, Krishna Patel, Danila Cuomo, et al.
Pediatric Nephrology (Berlin, Germany)|March 23, 2005
Dysregulation of renal MMP-3 and MMP-7 in canine X-linked Alport syndromeVelidi H Rao, George E Lees, Clifford E Kashtan, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|September 12, 2006
Gene expression analysis in a canine model of X-linked Alport syndromeKimberly A Greer, Marnie A Higgins, Melissa L Cox, et al.
Journal of Toxicologic Pathology|September 14, 2016
Non-proliferative and Proliferative Lesions of the Cardiovascular System of the Rat and MouseBrian R Berridge, Vasanthi Mowat, Hirofumi Nagai, et al.
Ultrastructural Pathology|April 29, 2026
Ultrastructural differences in the myocardium of cats with dilated cardiomyopathy eating high- versus low-pulse dietsMark D Bilger, Brian R Berridge, Gregory M Hendricks, et al.
Circulation Research|October 11, 2019
Workshop Report: FDA Workshop on Improving Cardiotoxicity Assessment With Human-Relevant PlatformsLi Pang, Philip Sager, Xi Yang, et al.
American Heart Journal|August 25, 2009
Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path InitiativeJonathan P Piccini, David J Whellan, Brian R Berridge, et al.
Kidney International|April 5, 2003
Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS)Velidi H Rao, George E Lees, Clifford E Kashtan, et al.
American Journal of Veterinary Research|November 12, 2025
Myocardial ultrastructure in dogs and cats: review of normal structure, abnormal findings, and rationale for use in veterinary medicineJasmine Huynh, Mark D Bilger, Brian R Berridge, et al.
American Heart Journal|June 23, 2009
A translational approach to detecting drug-induced cardiac injury with cardiac troponins: consensus and recommendations from the Cardiac Troponins Biomarker Working Group of the Health and Environmental Sciences InstituteBrian R Berridge, Syril Pettit, Dana B Walker, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
BMC Cardiovascular Disorders|September 27, 2025
Derivation of ultrasound and electrocardiogram cardiac reference ranges for Mus musculus using the collaborative cross and identification of new cardiac modelsJulia L Popp, Krishna Patel, Danila Cuomo, et al.
Pediatric Nephrology (Berlin, Germany)|March 23, 2005
Dysregulation of renal MMP-3 and MMP-7 in canine X-linked Alport syndromeVelidi H Rao, George E Lees, Clifford E Kashtan, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|September 12, 2006
Gene expression analysis in a canine model of X-linked Alport syndromeKimberly A Greer, Marnie A Higgins, Melissa L Cox, et al.
Journal of Toxicologic Pathology|September 14, 2016
Non-proliferative and Proliferative Lesions of the Cardiovascular System of the Rat and MouseBrian R Berridge, Vasanthi Mowat, Hirofumi Nagai, et al.
Ultrastructural Pathology|April 29, 2026
Ultrastructural differences in the myocardium of cats with dilated cardiomyopathy eating high- versus low-pulse dietsMark D Bilger, Brian R Berridge, Gregory M Hendricks, et al.
Circulation Research|October 11, 2019
Workshop Report: FDA Workshop on Improving Cardiotoxicity Assessment With Human-Relevant PlatformsLi Pang, Philip Sager, Xi Yang, et al.
American Heart Journal|August 25, 2009
Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path InitiativeJonathan P Piccini, David J Whellan, Brian R Berridge, et al.
Kidney International|April 5, 2003
Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS)Velidi H Rao, George E Lees, Clifford E Kashtan, et al.
American Journal of Veterinary Research|November 12, 2025
Myocardial ultrastructure in dogs and cats: review of normal structure, abnormal findings, and rationale for use in veterinary medicineJasmine Huynh, Mark D Bilger, Brian R Berridge, et al.
American Heart Journal|June 23, 2009
A translational approach to detecting drug-induced cardiac injury with cardiac troponins: consensus and recommendations from the Cardiac Troponins Biomarker Working Group of the Health and Environmental Sciences InstituteBrian R Berridge, Syril Pettit, Dana B Walker, et al.
Pageof 5